Schonfeld Strategic Advisors LLC Revance Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 62,300 shares of RVNC stock, worth $160,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,300

Previous 193,591 67.82%

Holding current value

$160,111

Previous $497,000 67.81%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.57 - $2.57 $337,417 - $337,417	-131,291 Reduced 67.82%	62,300 $160,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $4.73 $453,002 - $915,685	193,591 New	193,591 $497,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $374,193 - $721,336	64,405 Added 31.94%	266,039 $2.34 Million
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $1.35 Million - $2.95 Million	117,634 Added 140.04%	201,634 $2.31 Million
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $716,275 - $1.09 Million	28,999 Added 52.72%	84,000 $2.13 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $2.14 Million - $4.1 Million	-116,350 Reduced 67.9%	55,001 $1.77 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $834,439 - $1.4 Million	-45,548 Reduced 21.0%	171,351 $3.16 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $3.11 Million - $6.18 Million	216,899 New	216,899 $5.86 Million
Q3 2021 Nov 16, 2021	SELL	$25.78 - $33.21 $255,222 - $328,779	-9,900 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$26.8 - $31.84 $16,080 - $19,104	-600 Reduced 5.71%	9,900 $293,000
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $281,400 - $334,320	10,500 New	10,500 $311,000
Q2 2018 Aug 14, 2018	SELL	$27.45 - $33.35 $2.3 Million - $2.79 Million	-83,700 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$29.15 - $37.4 $339,801 - $435,971	-11,657 Reduced 12.22%	83,700 $2.58 Million
Q4 2017 Feb 14, 2018	BUY	$24.55 - $36.3 $2.34 Million - $3.46 Million	95,357	95,357 $3.41 Million

Others Institutions Holding RVNC

# of Institutions

233

Shares Held

82.1M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Revance Therapeutics, Inc. Transaction History